800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study (REIMAGINE)

view all Clinical Trials

Overview

This is a prospective, real-world, single arm, global, multi-centre study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma with an eosinophilic phenotype (SA-EP).

Clinical Trial Information

Protocol

TIRB#: 31826

Phase

4

Condition(s)

Asthma

Investigator

Kartik Shenoy, MD

Coordinator

Arwa Mukhtar

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Prospective, Real-World, Interventional Study To Evaluate The Effect Of Mepolizumab On Achieving Clinical Remission In Participants With Severe Asthma